Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Prices are delayed by 1 hour. Login or Sign Up for live updates.Prices are delayed by 1 hour. Login or Sign Up for live updates.
Price Analysis
About
Stock Analysis (SWOT)
QVT
Peer Stocks
1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
CIPLANSE
LAURUSLABSNSE
MANKINDNSE
DRREDDYNSE
AUROPHARMANSE
LUPINNSE
AHCLNSE
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Financial overview
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
CAGR%
Sales
Profits
Returns
ROE
| 10Y | 5Y | 3Y | TTM |
|---|---|---|---|
| - | - | - | 43% |
| - | - | - | 42% |
| - | - | - | 111% |
| 22% | 22% | 22% | 19% |
Peer Comparison
Symbol
SUNPHARMA
DIVISLAB
TORNTPHARM
ZYDUSLIFE
CIPLA
LAURUSLABS
MANKIND
DRREDDY
AUROPHARMA
LUPIN
AHCL
| Price | M.Cap (₹) | PE Ratio | EPS (₹) | EV/EBITDA | Annual PAT |
|---|---|---|---|---|---|
| 1,851 | ₹447476 Cr | 37 | 12.07 | 62.82 | ₹11479 Cr |
| 9,630 | ₹254764 Cr | 87.1 | 34.04 | 128.41 | ₹2568 Cr |
| 4,902 | ₹189423 Cr | 86.85 | 16.72 | 97.06 | ₹2163 Cr |
| 1,183.6 | ₹116658 Cr | 25.85 | 9.42 | 62.53 | ₹5040 Cr |
| 1,399 | ₹111484 Cr | 33.08 | 9.77 | 57.87 | ₹3879 Cr |
| 2,025.2 | ₹109943 Cr | 100.55 | 6.8 | 29.25 | ₹889 Cr |
| 2,480.5 | ₹101712 Cr | 49.79 | 13.75 | 71.08 | ₹1913 Cr |
| 1,202.6 | ₹101005 Cr | 31.35 | 5.32 | 63.99 | ₹4196 Cr |
| 1,720 | ₹99253 Cr | 26.73 | 17.95 | 96.84 | ₹3505 Cr |
| 2,090.3 | ₹96031 Cr | 17.37 | 30.95 | 154.35 | ₹5333 Cr |
| 28.58 | ₹1581 Cr | 55.44 | 0.13 | 0.57 | ₹29 Cr |
Profit & Loss
Consolidated
Standalone
Quarterly
Yearly
₹
%
Balance Sheet
Consolidated
Standalone
₹
%
Name
Equity And Liabilities
Share Capital
Total Reserves
Reserve excluding Revaluation Reserve
Shareholder's Funds
Minority Interest
Secured Loans
Unsecured Loans
Deferred Tax Assets / Liabilities
Long Term Provisions
Total Non-Current Liabilities
Current Liabilities
Trade Payables
Other Current Liabilities
Short Term Borrowings
Short Term Provisions
Total Current Liabilities
Total Liabilities
Contingent Liabilities
Total Debt
Assets
Gross Block
Less Accumulated Depreciation
Net Block
Non Current Investments
Long Term Investment
Long Term Loans & Advances
Total Non-Current Assets
Current Assets Loans & Advances
Currents Investments
Inventories
Sundry Debtors
Cash and Bank
Other Current Assets
Short Term Loans and Advances
Total Current Assets
Net Current Assets (Including Current Investments)
Total Assets
Book Value
Adjusted Book Value
| Mar 2026 | Mar 2025 |
|---|---|
| — | — |
| ₹53 Cr | ₹40 Cr |
| ₹177 Cr | ₹41 Cr |
| ₹177 Cr | ₹41 Cr |
| ₹230 Cr | ₹80 Cr |
| ₹25 Cr | ₹0 |
| ₹6 Cr | ₹5 Cr |
| ₹4 L | ₹34 Cr |
| ₹5 Cr | ₹2 Cr |
| ₹37 L | ₹24 L |
| ₹12 Cr | ₹41 Cr |
| — | — |
| ₹42 Cr | ₹20 Cr |
| ₹14 Cr | ₹4 Cr |
| ₹38 Cr | ₹28 Cr |
| ₹14 Cr | ₹8 Cr |
| ₹108 Cr | ₹60 Cr |
| ₹374 Cr | ₹181 Cr |
| ₹25 L | ₹0 |
| ₹44 Cr | ₹67 Cr |
| — | — |
| ₹84 Cr | ₹36 Cr |
| ₹26 Cr | ₹13 Cr |
| ₹58 Cr | ₹23 Cr |
| ₹98 L | ₹0 |
| ₹98 L | ₹0 |
| ₹7 Cr | ₹0 |
| ₹66 Cr | ₹23 Cr |
| — | — |
| ₹1 L | ₹91 L |
| ₹113 Cr | ₹50 Cr |
| ₹104 Cr | ₹75 Cr |
| ₹4 Cr | ₹1 Cr |
| ₹1 Cr | ₹1 Cr |
| ₹86 Cr | ₹30 Cr |
| ₹308 Cr | ₹158 Cr |
| ₹201 Cr | ₹98 Cr |
| ₹374 Cr | ₹181 Cr |
| ₹43 | ₹20 |
| ₹4 | ₹2 |
Cash Flow
Consolidated
Standalone
₹
%
Name
Profit Before Tax
Adjustment
Changes In working Capital
Cash Flow after changes in Working Capital
Cash Flow from Operating Activities
Cash Flow from Investing Activities
Cash Flow from Financing Activitie
Net Cash Inflow / Outflow
Opening Cash & Cash Equivalents
Closing Cash & Cash Equivalent
| Mar 2026 | Mar 2025 |
|---|---|
| ₹43 Cr | ₹27 Cr |
| ₹5 Cr | -₹56 L |
| -₹122 Cr | -₹54 Cr |
| -₹75 Cr | -₹28 Cr |
| -₹79 Cr | -₹23 Cr |
| -₹36 Cr | ₹3 Cr |
| ₹119 Cr | ₹19 Cr |
| ₹3 Cr | -₹82 L |
| ₹1 Cr | ₹2 Cr |
| ₹4 Cr | ₹1 Cr |
Fundamental Ratios
Consolidated
Standalone

No results found
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Technical meters
Oscillators
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 5
Bearish signals: 4 out of 9 oscillators
RSI
86.30Buy
STOCH %K
83.12Sell
MACD Level(12,26)
3.37Buy
Ultimate Oscillator
61.11Buy
Aroon Oscillator
66.00Buy
BOP
-0.43Sell
CCI
155.68Sell
Williams %R
-16.88Sell
Momentum
13.01Buy
Moving averages
Strong SellSellNeutralBuyStrong Buy
Bullish signals: 9
Bearish signals: 0 out of 9 moving averages
EMA 9
24.86Buy
SMA 9
24.21Buy
EMA 21
21.06Buy
SMA 21
19.41Buy
EMA 50
18.03Buy
SMA 50
16.73Buy
EMA 200
14.98Buy
SMA 200
14.33Buy
WMA 20
22.06Buy
Pivot
Pivot
Classic
Resistance 5
48.13
Resistance 4
43.39
Resistance 3
38.65
Resistance 2
33.91
Resistance 1
31.80
Pivot
29.17
Support 1
27.06
Support 2
24.43
Support 3
19.69
Support 4
14.95
Support 5
10.21
High & lows
1 Day
1 Week
1 Month
3 Months
6 Months
Year to Date
1 Year
3 Years
5 Years
10 Years
All Time
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Shareholding summary
Shareholding Pattern
Quarterly
Yearly
Name
Promoters
FII
DII - Others
DII - MFs
Retail & Others
| Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| 52.68% | 52.68% | 52.68% | 52.68% |
| 1.67% | 0.32% | 0.23% | 0.00% |
| 1.23% | 4.60% | 4.49% | 2.83% |
| 0.00% | 0.00% | 0.00% | 0.00% |
| 44.42% | 42.40% | 42.60% | 44.49% |
Bulk & block deals
Name
Hrti Private Limited
Qe Securities Llp
Junomoneta Finsol Private Limited
Microcurves Trading Private Limited
Irage Broking Services Llp
Hrti Private Limited
Qe Securities Llp
Junomoneta Finsol Private Limited
Microcurves Trading Private Limited
Irage Broking Services Llp
| Deal Date | Action | Deal Value | Deal Price | Qty Traded | Deal Type | %Stake Traded | Exchange |
|---|---|---|---|---|---|---|---|
| 23 Sep 2026 | Purchase | 37.97 Cr | ₹28.78 | 1.32 Cr | Bulk | 24.824498 | NSE |
| 23 Sep 2026 | Purchase | 15.32 Cr | ₹28.76 | 53.28 L | Bulk | 10.023401 | NSE |
| 23 Sep 2026 | Purchase | 14.44 Cr | ₹28.91 | 49.96 L | Bulk | 9.398651 | NSE |
| 23 Sep 2026 | Purchase | 8.35 Cr | ₹28.84 | 28.97 L | Bulk | 5.44972 | NSE |
| 23 Sep 2026 | Purchase | 5.91 Cr | ₹29.31 | 20.17 L | Bulk | 3.794168 | NSE |
| 23 Sep 2026 | Sell | 38.53 Cr | ₹29.02 | 1.33 Cr | Bulk | 24.979863 | NSE |
| 23 Sep 2026 | Sell | 15.42 Cr | ₹28.93 | 53.29 L | Bulk | 10.026468 | NSE |
| 23 Sep 2026 | Sell | 14.45 Cr | ₹28.92 | 49.96 L | Bulk | 9.398655 | NSE |
| 23 Sep 2026 | Sell | 8.35 Cr | ₹28.84 | 28.97 L | Bulk | 5.44972 | NSE |
| 23 Sep 2026 | Sell | 8.32 Cr | ₹28.92 | 28.75 L | Bulk | 5.409447 | NSE |
Insider trading & SAST
Client name
Neomile Growth Fund - Series I
Neomile Growth Fund Series I
Neomile Growth Fund - Series I
Neomile Growth Fund Series 1
Neomile Growth Fund Series I
Neomile Growth Fund - Series I & Neomile Corporate Advisory Ltd
Astrone Capital Vcc - Arven
Neomile Corporate Advisory Ltd
Astone Capital Vcc - Arven & Astone Capital Vcc - Alpha A2
Neomile Corporate Advisory Ltd & Neomile Growth Fund - Series I
| Reported on | Client category | Action | %Stake traded | Holding % post deal | Deal value | Deal price | Qty traded | Deal period | Deal mode | Post transaction holding | Insider/SAST | Regulation type | Security type |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 08 Apr 2026 | Other | Disposal | 0.76 | 4.4 | 0 | — | 4.07 L | 08 Mar 2026 - 10 Mar 2026 | Market | 23,38,041 | SAST | 29(2) | — |
| 10 Feb 2026 | Other | Disposal | 2.46 | 5.16 | 0 | — | 13.07 L | 06 Nov 2025 - 09 Jan 2026 | Market | 27,45,296 | SAST | 29(2) | — |
| 07 Nov 2025 | Other | Disposal | 2.78 | 7.62 | 0 | — | 14.76 L | 03 Nov 2025 - 04 Nov 2025 | Market | 40,52,675 | SAST | 29(2) | — |
| 06 Nov 2025 | Other | Disposal | 2.78 | 7.62 | 0 | — | 14.76 L | 03 Nov 2025 - 04 Nov 2025 | Market | 40,52,675 | SAST | 29(2) | — |
| 17 Oct 2025 | Other | Disposal | 2.51 | 10.4 | 0 | — | 13.33 L | 19 Sep 2025 - 24 Sep 2025 | Market | 55,28,667 | SAST | 29(2) | — |
| 17 Oct 2025 | Other | Disposal | 2.51 | 10.4 | 0 | — | 13.33 L | 19 Sep 2025 - 24 Sep 2025 | Market | 55,28,667 | SAST | 29(2) | — |
| 30 Sep 2025 | Other | Disposal | 4.78 | 4.49 | 0 | — | 25.43 L | 03 Sep 2025 - 09 Sep 2025 | Market | 23,87,317 | SAST | 29(2) | — |
| 30 Sep 2025 | Other | Acquisition | 4.24 | 12.91 | 0 | — | 22.54 L | 09 Sep 2025 - 11 Sep 2025 | Market | 68,61,261 | SAST | 29(2) | — |
| 30 Sep 2025 | Other | Acquisition | 9.28 | 9.28 | 0 | — | 49.30 L | 01 Sep 2025 | Public Issue | 49,30,241 | SAST | 29(1) | — |
| 30 Sep 2025 | Other | Acquisition | 8.67 | 8.67 | 0 | — | 46.07 L | 03 Sep 2025 - 05 Sep 2025 | Market | 46,06,839 | SAST | 29(1) | — |
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Anlon Healthcare is a chemical manufacturing company, engaged in manufacturing of pharmaceutical intermediates and Active Pharmaceutical Ingredients (APIs), which are supplied to customers both in India and international markets. Its
Corporate Actions
Date
Type
Details
Company details
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
Corporate filings & documents
Announcements
Annual reports
Concalls & investor presentations
Anlon Healthcare Share Price
28.58-1.10 (-3.71%)
+103.34% past 1 Year
News
Anlon Healthcare guides for 30 percent revenue CAGR over next three years
Equity
AHCL
Anlon Healthcare Q1 revenue declines year-on-year, modest topline pressure observed
Equity
AHCL
Anlon Healthcare reports higher Q1 EBITDA and improved margin year on year
Equity
AHCL
Anlon Healthcare Q1 net profit rises year-on-year to Rs 4.80 crores
Equity
AHCL
Anlon Healthcare informs about invitation for tv interview
Equity
AHCL
Anlon Healthcare informs about conference call
Equity
AHCL
Anlon Healthcare informs about press release
Equity
AHCL
Anlon Healthcare informs about newspaper advertisement
Equity
AHCL
Anlon Healthcare informs about press release
Equity
AHCL
Anlon Healthcare reports Profit after tax of 9.79 Crores, in the March 2026 quarter
Equity
AHCL
Anlon Healthcare Q4 EBITDA declines with significant compression in margins YoY
Equity
AHCL
Anlon Healthcare Q4 reports year-on-year revenue growth for FY2024 period
Equity
AHCL
Anlon Healthcare reports lower Q4 net profit year on year
Equity
AHCL
Anlon Healthcare informs about allotment of bonus equity shares
Equity
AHCL
Anlon Healthcare informs about share purchase agreement
Equity
AHCL
Anlon Healthcare surges on the BSE
Equity
AHCL
Anlon Healthcare to acquire 63.98% of equity share capital of Remember India Health Links
Equity
AHCL
Anlon Healthcare Acquires 63.98% Stake in Remember India Health Links for Rs 5.38 Cr
Equity
AHCL
Anlon Healthcare shines on acquiring 56.67% equity shareholding in Bizotic Life Science
Equity
AHCL
Anlon Healthcare acquires 56.67% equity shareholding in Bizotic Life Science
Equity
AHCL

